Dayu Chen

Dr. Dayu Chen

Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in Infectious Diseases and Therapy
Verified
Journal Article
Open access
PDF file
GZGuanhao Zheng
Guanhao Zheng
JCJiaqi Cai
Jiaqi Cai
LZLiang Zhang
Liang Zhang
Dayu ChenDayu Chen
Dayu Chen
LWLinyu Wang
Linyu Wang
JHJuan He
Juan He
Introduction Considering the importance of ceftazidime/avibactam (CAZ/AVI) and polymyxin B (PMB) in treating carbapenem-resistant Klebsiella pneumoniae (CRKP) infection, it is essential to evaluate the efficacy and safety of these agents and provide appropriate medical advice to clinical specialists. Methods We conducted a retrospective cohort study in two Chinese tertiary hospitals for critically ill patients with CRKP infection who received at least 24-h CAZ/AVI-based or PMB-based treatment. A binary logistic model and a Cox proportional hazards regression model were constructed to analyze variables that could potentially affect 30-day microbiological eradication and all-cause mortality, respectively. Results From January 2019 to December 2021, 164 eligible patients were divided into CAZ/AVI and PMB cohorts. A notably lower 30-day mortality rate (35.4% vs 69.5%, P < 0.001) and a higher 30-day microbiological eradication rate (80.5% vs 32.9%, P < 0.001) were observed for patients receiving CAZ/AVI-based treatment, compared with cases in the PMB group. A longer antimicrobial treatment duration (> 7 days) could also significantly decrease the mortality rate and increase the microbiological eradication rate. Female patients had a higher survival rate than male patients. Age over 65 years, sepsis, continuous renal replacement therapy, and organ transplantation were identified as negative factors for survival. In the subgroup analysis, CAZ/AVI combined with tigecycline or amikacin could effectively lower mortality. According to safety evaluation results, potential elevation of hepatic enzymes was associated with CAZ/AVI-based treatment, while renal impairment was probably related to PMB-based treatment. Conclusions CAZ/AVI was more effective than PMB in treating CRKP-infected patients. Tigecycline and amikacin were proven to be beneficial as concomitant agents in combination with CAZ/AVI. A treatment period lasting over 7 days was recommended. Hepatoxicity of CAZ/AVI and nephrotoxicity of PMB should be monitored carefully. Further well-designed studies should be performed to verify our conclusion.

19 March 2020 in Surgical Infections
Verified
Journal Article
Closed access
XCXiaoyuan Chen
Xiaoyuan Chen
SSShiquan Sun
Shiquan Sun
XYXiaopeng Yan
Xiaopeng Yan
XFXu Fu
Xu Fu
YFYinyin Fan
Yinyin Fan
LMLiang Mao
Liang Mao
Background: Despite advances in surgical techniques and peri-operative management, post-operative infectious complications still are common after perihilar cholangiocarcinoma (PHCC). This study investigated the predictive factors and microbial spectrum for infections after hepatectomy with cholangiojejunostomy performed to treat PHCC. Methods: A total of 70 consecutive patients, who underwent hepatectomy with cholangiojejunostomy by the same surgeons at a tertiary referral medical center between September 2010 and January 2019, were enrolled. Clinical data were reviewed for multivariable analysis to find independent risk factors for infectious complications. Microorganisms isolated from bile and infection sites were counted to explore the microbial spectrum. Results: A total of 43 patients (61.4%) suffered post-operative infections (33 with surgical site infection [SSI], four with bacteremia, three with pneumonia, 10 with cholangitis, and two with fungus infectious stomatitis), and 28 of them (65.1%) had a positive bile culture. Four independent risk factors were identified: male sex (odds ratio [OR] 12.737; 95% confidence interval [CI] 2.298–70.611; p = 0.004), red blood cell (RBC) count <3.8 × 10 12 /L (OR 5.085; 95% CI 1.279–20.211; p = 0.021), total cholesterol (TC) 145 mmol/L (OR 10.387; 95% CI 1.559–69.201; p = 0.016) on post-operative day (POD) 1. A total of 217 and 196 microorganisms were cultured from 311 and 627 specimens, respectively, collected from pre-/intra-operative bile and possible infection sites. Staphylococcus , Enterococcus , Acinetobacter, Streptococcus, and Escherichia were the most common findings of bile culture. The first five organisms most frequently isolated from infection sites were Enterococcus, Staphylococcus, Klebsiella, Acinetobacter, and Candida . A total of 18 patients (64.3%) had at least one species isolated from infection sites that had appeared in a previous bile culture. Conclusions: Male sex, erythrocytopenia, hypocholesterolemia, and hypernatremia on POD 1 are independent risk factors for infectious complications. For patients without positive bile cultures, third-generation cephalosporins could be considered as the prophylactic antibiotic. It is important to monitor the pathogens throughout the hospital stay.

15 August 2024 in Clinical and Translational Science
Verified
Journal Article
Open access
JXJinkun Xia
Jinkun Xia
BFBoqi Fu
Boqi Fu
ZWZhe Wang
Zhe Wang
GWGaolin Wen
Gaolin Wen
QGQuanshui Gu
Quanshui Gu
HRHaozhen Ren
Haozhen Ren
Ferroptosis is a novel, iron‐dependent regulatory cell death mainly caused by an imbalance between the production and degradation of intracellular reactive oxygen species (ROS). Recently, ferroptosis induction has been considered a potential therapeutic approach for hepatocellular carcinoma (HCC). Fibroblast growth factor 21 (FGF21) is a new modulator of ferroptosis; however, the regulatory role of FGF21 in HCC ferroptosis has not been investigated. In this study, we explored the role of FGF21 and its underlying molecular mechanism in the ferroptotic death of HCC cells. We identified Major vault protein (MVP) as a target of FGF21 and revealed that knockdown of MVP inhibited the lipid peroxidation levels of HCC cells by decreasing NADPH oxidase 4 (NOX4, a major source of ROS) transcription, thereby attenuating the effect of FGF21‐mediated ferroptosis. On the other hand, MVP overexpression showed the opposite results. Mechanistically, MVP binds to IRF1 and thus interferes with the interaction between IRF1 and the YAP1 promoter, leading to an increase in NOX4 transcription. Importantly, forced expression of IRF1 or downregulation of YAP1 partially reversed the effect of MVP overexpression on HCC ferroptosis. Furthermore, the results in xenograft tumor models suggested that overexpression of MVP can efficiently increase the level of lipid peroxidation in vivo. Taken together, these results provide new insights into the regulatory mechanism of ferroptosis in HCC.

30 October 2025 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
Dayu ChenDayu Chen
Dayu Chen
JPJunping Pan
Junping Pan
YLYao Lu
Yao Lu
JGJiayue Guo
Jiayue Guo
ZWZhongxia Wang
Zhongxia Wang
XZXinhua Zhu
Xinhua Zhu

16 May 2025 in Smart Medicine
Verified
Journal Article
Open access
HDHaoran Ding
Haoran Ding
LXLingling Xue
Lingling Xue
SZShaoshi Zhu
Shaoshi Zhu
ZWZiyu Wang
Ziyu Wang
HGHuan Gui
Huan Gui
Dayu ChenDayu Chen
Dayu Chen
Polyamine metabolism is a key regulator of cellular proliferation and immune modulation, and its dysregulation is implicated in multiple carcinoma pathogenesis. Macrophages also greatly influence tumor progression by regulating the immune microenvironment. However, the role of polyamine metabolism in thyroid cancer macrophages remains understudied. This study explores the connection between polyamine metabolism and macrophages in thyroid cancer. Using the THCA dataset gene expression analysis and single‐cell data, we identified macrophage subpopulations. We assessed immune scores, matrix scores, immune checkpoint scores, and immune cell types using Bulk‐RNA data and the TIDE platform to predict immune checkpoint inhibitor responses. Clinical specimens validated our findings. Our results show a significant association between polyamine metabolism and the clinical and biological characteristics of thyroid cancer, including macrophage trajectory. Notably, macrophage subpopulations affected by polyamine metabolism have strong prognostic value, especially in immunotherapy patients. We found that changes in these subpopulations correlate with thyroid cancer development, and tumor tissue can regulate macrophage polyamine metabolism. This study provides new insights into how polyamine metabolism affects macrophages and the tumor microenvironment, influencing tumor growth and anti‐tumor immune responses in thyroid cancer.

12 June 2025 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
JKJingjing Kan
Jingjing Kan
YCYechao Chen
Yechao Chen
QGQiaoling Gu
Qiaoling Gu
NHNa Hu
Na Hu
YQYanli Qiao
Yanli Qiao
HZHaixia Zhang
Haixia Zhang
Recent studies suggest histamine H1 receptor antagonists (H1RAs) may elevate broad dementia events risk, though real-world data remain scarce. This pharmacovigilance study analyzed FDA Adverse Event Reporting System (FAERS), Japanese Adverse Drug Event Report (JADER), and Canada Vigilance Adverse Reaction (CVAR) databases from January 2004 to June 2024. Using disproportionality analyses such as the reporting odds ratio (ROR) and proportion reporting ratio (PRR), time-to-onset analysis, propensity score matching, and multivariate regression, we compared broad dementia event signals among first-generation H1RAs (FG-H1RAs), second-generation H1RAs (SG-H1RAs), and benzodiazepines (BDs). According to the FAERS database, FG-H1RAs (ROR = 3.33, 95%CI 3.22-3.44; PRR = 3.11, χ2 = 5426.01), SG-H1RAs (ROR = 2.03, 95%CI 1.98-2.07; PRR = 1.97, χ2 = 3706.58), and BDs (ROR = 2.74, 95%CI 2.68-2.80; PRR = 2.6, χ2 = 8338.34) were significantly associated with broad dementia events, with FG-H1RAs having a stronger association with broad dementia events compared to SG-H1RAs (aROR = 0.60, 95%CI 0.54-0.67, p < 0.001). Analysis of the JADER and CVAR databases yielded similar results. FG-H1RAs exhibited immediate broad dementia events reporting (median = 0 days), while SG-H1RAs showed delayed onset (median = 1 day), both with early risk decay. This study provides evidence for the association between H1RAs treatment and broad dementia events, highlighting signaling differences among H1RAs. However, large-scale, high-quality epidemiological studies are still needed for validation.